583
Views
43
CrossRef citations to date
0
Altmetric
Research Article

Interim [18F]fluorodeoxyglucose positron emission tomography imaging in stage I–II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?

, , , , , , , , , , & show all
Pages 2143-2150 | Received 20 Dec 2012, Accepted 08 Mar 2012, Published online: 28 Aug 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sarah A. Milgrom, Bouthaina S. Dabaja & N. George Mikhaeel. (2021) Advanced-stage Hodgkin lymphoma: have effective therapy and modern imaging changed the significance of bulky disease?. Leukemia & Lymphoma 62:7, pages 1554-1562.
Read now
Deniz Kahraman, Sebastian Theurich, Achim Rothe, Georg Kuhnert, Stephanie Sasse, Christoph Scheid, Markus Dietlein, Alexander Drzezga, Michael von Bergwelt-Baildon & Carsten Kobe. (2014) 18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma. Leukemia & Lymphoma 55:4, pages 811-816.
Read now
Rebecca L. Elstrom. (2012) Interim response assessment for Hodgkin lymphoma: size matters. Leukemia & Lymphoma 53:11, pages 2095-2096.
Read now

Articles from other publishers (39)

Patrick Veit-Haibach, Håkan Ahlström, Ronald Boellaard, Roberto C. Delgado Bolton, Swen Hesse, Thomas Hope, Martin W. Huellner, Andrei Iagaru, Geoffrey B. Johnson, Andreas Kjaer, Ian Law, Ur Metser, Harald H. Quick, Bernhard Sattler, Lale Umutlu, Greg Zaharchuk & Ken Herrmann. (2023) International EANM-SNMMI-ISMRM consensus recommendation for PET/MRI in oncology. European Journal of Nuclear Medicine and Molecular Imaging.
Crossref
Theodoros P. Vassilakopoulos, Athanassios Liaskas, Alexia Piperidou, Maria Ioakim & Vassilios Prassopoulos. 2022. Artificial Intelligence in PET/CT Oncologic Imaging. Artificial Intelligence in PET/CT Oncologic Imaging 109 151 .
Angela Aldin, Lisa Umlauff, Lise J Estcourt, Gary Collins, Karel GM Moons, Andreas Engert, Carsten Kobe, Bastian von Tresckow, Madhuri Haque, Farid Foroutan, Nina Kreuzberger, Marialena Trivella & Nicole Skoetz. (2020) Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Cochrane Database of Systematic Reviews 2020:8.
Crossref
Paul J. Bröckelmann & Lena Specht. 2020. Hodgkin Lymphoma. Hodgkin Lymphoma 145 169 .
Katherine A. Zukotynski, Phillip H. Kuo, Chun K. Kim & Rathan M. Subramaniam. 2020. Therapy Response Imaging in Oncology. Therapy Response Imaging in Oncology 255 272 .
Hina Shah & Heather Jacene. 2020. Therapy Response Imaging in Oncology. Therapy Response Imaging in Oncology 177 200 .
Angela Aldin, Lisa Umlauff, Lise J Estcourt, Gary Collins, Karel GM Moons, Andreas Engert, Carsten Kobe, Bastian von Tresckow, Madhuri Haque, Farid Foroutan, Nina Kreuzberger, Marialena Trivella & Nicole Skoetz. (2019) Interim PET-results for prognosis in adults with Hodgkin lymphoma: a systematic review and meta-analysis of prognostic factor studies. Cochrane Database of Systematic Reviews.
Crossref
Xiaoqian Li, Xun Sun, Juan Li, Zijian Liu, Mi Mi, Fang Zhu, Gang Wu, Xiaoli Lan & Liling Zhang. (2019) Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B‐cell lymphoma. Cancer Medicine 8:11, pages 5012-5022.
Crossref
Paola Anna Erba, Martina Sollini, Roberto Boni & Sara Galimberti. 2019. Nuclear Medicine Textbook. Nuclear Medicine Textbook 655 705 .
Bruce D. Cheson. (2018) PET/CT in Lymphoma: Current Overview and Future Directions. Seminars in Nuclear Medicine 48:1, pages 76-81.
Crossref
Theodoros P. Vassilakopoulos & Vassilios K. Prassopoulos. 2018. Imaging in Clinical Oncology. Imaging in Clinical Oncology 619 647 .
Sarah A. Milgrom, Chelsea C. Pinnix, Hubert Chuang, Yasuhiro Oki, Mani Akhtari, Osama Mawlawi, Naveen Garg, Jillian R. Gunther, Jay P. Reddy, Grace L. Smith, Eric Rohren, Frederick B. Hagemeister, Hun J. Lee, Luis E. Fayad, Wenli Dong, Eleanor M. Osborne, Zeinab Abou Yehia, Michelle Fanale & Bouthaina S. Dabaja. (2017) Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?. British Journal of Haematology 179:3, pages 488-496.
Crossref
Sarah A. Milgrom, Wenli Dong, Mani Akhtari, Grace L. Smith, Chelsea C. Pinnix, Osama Mawlawi, Eric Rohren, Naveen Garg, Hubert Chuang, Zeinab Abou Yehia, Jay P. Reddy, Jillian R. Gunther, Joseph D. Khoury, Tina Suki, Eleanor M. Osborne, Yasuhiro Oki, Michelle Fanale & Bouthaina S. Dabaja. (2017) Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. International Journal of Radiation Oncology*Biology*Physics 97:2, pages 333-338.
Crossref
Mateen C. Moghbel, Erik Mittra, Andrea Gallamini, Ryan Niederkohr, Delphine L. Chen, Katherine Zukotynski, Helen Nadel & Lale Kostakoglu. (2017) Response Assessment Criteria and Their Applications in Lymphoma: Part 2. Journal of Nuclear Medicine 58:1, pages 13-22.
Crossref
Fabrice Delbary, Sara Garbarino & Valentina Vivaldi. (2016) Compartmental analysis of dynamic nuclear medicine data: models and identifiability. Inverse Problems 32:12, pages 125010.
Crossref
L. Valls, C. Badve, S. Avril, K. Herrmann, P. Faulhaber, J. O'Donnell & N. Avril. (2016) FDG-PET imaging in hematological malignancies. Blood Reviews 30:4, pages 317-331.
Crossref
Michael Coyle, Lale Kostakoglu & Andrew M. Evens. (2016) The evolving role of response-adapted PET imaging in Hodgkin lymphoma. Therapeutic Advances in Hematology 7:2, pages 108-125.
Crossref
Wolfgang Mohnike, Gustav Hör & Andreas Hertel. 2016. PET/CT-Atlas. PET/CT-Atlas 369 414 .
Andrea Gallamini, Anna Borra & Colette Zwarthoed. 2016. PET Scan in Hodgkin Lymphoma. PET Scan in Hodgkin Lymphoma 31 64 .
Theodoros P. Vassilakopoulos, Phoivi Rondogianni, Sofia N. Chatziioannou, Effimia P. Vrakidou, Vasileios I. Telonis, Roxani D. Efthymiadou, John A. Andreou & Vassilios K. Prassopoulos. 2016. PET/CT in Lymphomas. PET/CT in Lymphomas 51 107 .
Theodoros P. Vassilakopoulos, Vassilios Prassopoulos, Phoivi Rondogianni, Sofia Chatziioannou, Kostas Konstantopoulos & Maria K. Angelopoulou. (2015) Role of FDG-PET/CT in staging and first-line treatment of Hodgkin and aggressive B-cell lymphomas. memo - Magazine of European Medical Oncology 8:2, pages 105-114.
Crossref
Bruce D. Cheson. (2015) Rethinking Clinical Response and Outcome Assessment in a Biologic Age. Current Oncology Reports 17:6.
Crossref
Luigi Rigacci, Benedetta Puccini, Pier Luigi Zinzani, Alberto Biggi, Antonio Castagnoli, Francesco Merli, Monica Balzarotti, Caterina Stelitano, Michele Spina, Umberto Vitolo, Vittorio Stefoni, Alessandro Levis, Manuel Gotti, Sancetta Rosaria, Stefani Piero Maria, Alberto Bosi & Andrea Gallamini. (2015) The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL). American Journal of Hematology 90:6, pages 499-503.
Crossref
Craig H. Moskowitz & Heiko Schöder. (2015) Current Status of the Role of PET Imaging in Diffuse Large B-Cell Lymphoma. Seminars in Hematology 52:2, pages 138-142.
Crossref
Sree Harsha Tirumani, Ann S. LaCasce & Heather A. Jacene. (2015) Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma. PET Clinics 10:2, pages 207-225.
Crossref
Lena Specht & Dirk Hasenclever. 2015. Hodgkin Lymphoma. Hodgkin Lymphoma 131 155 .
Vasiliki Leventaki, Joseph D. Khoury & Stephan D. Voss. 2015. Pediatric Malignancies: Pathology and Imaging. Pediatric Malignancies: Pathology and Imaging 103 149 .
Andrew M. Evens & Lale Kostakoglu. (2014) The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease. Hematology 2014:1, pages 135-143.
Crossref
Andrew M. Evens & Lale Kostakoglu. (2014) The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease. Blood 124:23, pages 3356-3364.
Crossref
Bruce D. ChesonRichard I. FisherSally F. BarringtonFranco CavalliLawrence H. SchwartzEmanuele ZuccaT. Andrew Lister. (2014) Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification. Journal of Clinical Oncology 32:27, pages 3059-3067.
Crossref
Sally F. BarringtonN. George MikhaeelLale KostakogluMichel MeignanMartin HutchingsStefan P. MüellerLawrence H. SchwartzEmanuele ZuccaRichard I. FisherJudith TrotmanOtto S. HoekstraRodney J. HicksMichael J. O'DohertyRoland HustinxAlberto BiggiBruce D. Cheson. (2014) Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Journal of Clinical Oncology 32:27, pages 3048-3058.
Crossref
Lale Kostakoglu & Bruce D. Cheson. (2014) Current role of FDG PET/CT in lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 41:5, pages 1004-1027.
Crossref
Martin Hutchings. (2014) FDG-PET Response–adapted Therapy. Hematology/Oncology Clinics of North America 28:1, pages 87-103.
Crossref
Theodoros P. Vassilakopoulos & Vassilios K. Prassopoulos. 2014. Imaging in Clinical Oncology. Imaging in Clinical Oncology 249 265 .
Maria Chiara Gaeta & Karin Anna Herrmann. 2014. PET/MRI. PET/MRI 71 78 .
Stephan D. Voss. (2013) Surveillance Imaging in Pediatric Hodgkin Lymphoma. Current Hematologic Malignancy Reports 8:3, pages 218-225.
Crossref
Lale Kostakoglu & Andrea Gallamini. (2013) Interim 18 F-FDG PET in Hodgkin Lymphoma: Would PET-Adapted Clinical Trials Lead to a Paradigm Shift? . Journal of Nuclear Medicine 54:7, pages 1082-1093.
Crossref
Shonit Punwani, Stuart A. Taylor, Ziauddin Z. Saad, Alan Bainbridge, Ashley Groves, Stephen Daw, Ananth Shankar, Steve Halligan & Paul D. Humphries. (2012) Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?. European Journal of Nuclear Medicine and Molecular Imaging 40:3, pages 373-385.
Crossref
Andrea Gallamini & Lale Kostakoglu. (2012) Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?. Blood 120:25, pages 4913-4920.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.